Antabio
Drugs for antibiotics-resistant infections
Antabio has raised €8.0M across 1 funding round from 1 investor, most recently a round in Jul 2017. Based in France; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€8.0M
€8,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2017-07
latest 2017-07
Funding by year
EUR raised per yearAntabio — funding by year — interactive chart.
Data table
| Antabio — funding by year | |
|---|---|
| 2017 | €8.0M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-07-04 | Other | €8.0M | Carb-X | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData